Global Markets for Ashtma and COPD Drugs

December 29, 2009

Wellesley, Mass. – According to a new technical market research report, GLOBAL MARKETS FOR ASTHMA AND COPD DRUGS (PHM059A) from BCC Research (www.bccresearch.com), the global market for drugs to treat asthma and chronic obstructive pulmonary disease (COPD) is estimated to be worth nearly $27 billion in 2009. That is expected to increase to $31.4 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 3.3%.

The largest segment of the market, asthma drugs, is expected to increase at a CAGR of 1.2%, from $16.2 billion in 2009 to $17.2 billion in 2014.

The other segment, COPD drugs, is estimated to be worth $10.5 billion in 2009, and is projected to increase to $14.2 billion in 2014, for a 5-year CAGR of 6.1%

SUMMARY FIGURE

GLOBAL MARKET FOR ASTHMA AND COPD DRUGS, 2007-2014

($ MILLIONS)

To Contact us, click here

Source: BCC Research

Asthma and COPD are two diseases experiencing increasing prevalence globally due to a combination of factors, including the aging of the population and rising pollution levels, particularly in emerging countries. COPD is one of the top five causes of disability and death in industrialized countries and the fourth-leading cause of death globally.

In 2008, there were six blockbuster drugs in this market, including GlaxoSmithKline’s Advair/Seretide, Merck’s Singulair, Boehringer Ingelheim’s Spiriva, and AstraZeneca’s Symbicort. These drugs have enjoyed tremendous commercial success since their introduction to market; however, the revenues of several blockbuster drugs are projected to be threatened by expected patent expirations and increasing market competition resulting from the launch of new products and generic versions of currently marketed drugs.

This study outlines the industry structure, competitive aspects, current developments, and future trends in the market, to assist in identifying areas of commercial interest and potential in the asthma and COPD indications.

This report provides information that is useful for business planners, market researchers, marketers, business developers, investors, venture capitalists, consultants, and anyone who wants to understand or invest in this market.

Global Markets for Asthma and COPD Drugs( PHM059A )
Publish Date: Oct 2009

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.

BCC Library Membership Benefits

Unlimited Access to Market Research Reports for Academic Institutions and Corporations.

Custom Research

Tailored solutions across industries for your unique business needs.

Global Markets for Asthma and COPD Drugs

Customize This Report

Reports from Pharmaceuticals

Browse by Year

2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment

Global Markets for Ashtma and COPD Drugs

BCC Library Membership Benefits

Custom Research

More in Pharmaceuticals

Reports from Pharmaceuticals

Recent News

Browse by Year